RecruitingPHASE1, PHASE2NCT07222631

SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas

Studying Non-Hodgkin lymphoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, San Diego
Principal Investigator
Peter Vu, MD, MD
University of California, San Diego
Intervention
SB-4826(drug)
Enrollment
48 enrolled
Eligibility
18 years · All sexes
Timeline
2026 – 2033

Study locations (1)

Collaborators

The Institute for Follicular Lymphoma Innovation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07222631 on ClinicalTrials.gov

Other trials for Non-Hodgkin lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Non-Hodgkin lymphoma →

← Back to all trials